http://bio2rdf.org/drugbank_resource:DB00203_DB00872_nanopub.RAOp_x3rtCMBNgEaUesKgW3AqrTRwagCaBYFcHKzsfc90#head http://bio2rdf.org/drugbank_resource:DB00203_DB00872_nanopub.RAOp_x3rtCMBNgEaUesKgW3AqrTRwagCaBYFcHKzsfc90 http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00203_DB00872_nanopub.RAOp_x3rtCMBNgEaUesKgW3AqrTRwagCaBYFcHKzsfc90#assertion http://bio2rdf.org/drugbank_resource:DB00203_DB00872_nanopub.RAOp_x3rtCMBNgEaUesKgW3AqrTRwagCaBYFcHKzsfc90 http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00203_DB00872_nanopub.RAOp_x3rtCMBNgEaUesKgW3AqrTRwagCaBYFcHKzsfc90#provenance http://bio2rdf.org/drugbank_resource:DB00203_DB00872_nanopub.RAOp_x3rtCMBNgEaUesKgW3AqrTRwagCaBYFcHKzsfc90 http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00203_DB00872_nanopub.RAOp_x3rtCMBNgEaUesKgW3AqrTRwagCaBYFcHKzsfc90#publicationInfo http://bio2rdf.org/drugbank_resource:DB00203_DB00872_nanopub.RAOp_x3rtCMBNgEaUesKgW3AqrTRwagCaBYFcHKzsfc90 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00203_DB00872_nanopub.RAOp_x3rtCMBNgEaUesKgW3AqrTRwagCaBYFcHKzsfc90#assertion http://bio2rdf.org/drugbank:DB00203 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00203_DB00872 http://bio2rdf.org/drugbank:DB00872 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00203_DB00872 http://bio2rdf.org/drugbank_resource:DB00203_DB00872 http://purl.org/dc/terms/identifier drugbank_resource:DB00203_DB00872 http://bio2rdf.org/drugbank_resource:DB00203_DB00872 http://purl.org/dc/terms/title DDI between Sildenafil and Conivaptan - CYP3A4 Inhibitors (Strong) such as conivaptan may increase the serum concentration of Sildenafil. When sildenanfil is used for treatment of pulmonary arterial hypertension, concurrent use with strong CYP3A4 inhibitors is not recommended. When sildenafil is used for treatment of erectile dysfunction, consider using a lower starting dose of 25 mg in patients who are also taking a strong CYP3A4 inhibitor. Due to the particularly strong effects of ritonavir, sildenafil (for erectile dysfunction) doses greater than 25 mg per 48 hours are not recommended. Of note, the interaction between CYP3A4 inhibitors and sildenafil is predicted to be greater with orally administered than with injected sildenafil. http://bio2rdf.org/drugbank_resource:DB00203_DB00872 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00203_DB00872 http://www.w3.org/2000/01/rdf-schema#label DDI between Sildenafil and Conivaptan - CYP3A4 Inhibitors (Strong) such as conivaptan may increase the serum concentration of Sildenafil. When sildenanfil is used for treatment of pulmonary arterial hypertension, concurrent use with strong CYP3A4 inhibitors is not recommended. When sildenafil is used for treatment of erectile dysfunction, consider using a lower starting dose of 25 mg in patients who are also taking a strong CYP3A4 inhibitor. Due to the particularly strong effects of ritonavir, sildenafil (for erectile dysfunction) doses greater than 25 mg per 48 hours are not recommended. Of note, the interaction between CYP3A4 inhibitors and sildenafil is predicted to be greater with orally administered than with injected sildenafil. [drugbank_resource:DB00203_DB00872] http://bio2rdf.org/drugbank_resource:DB00203_DB00872_nanopub.RAOp_x3rtCMBNgEaUesKgW3AqrTRwagCaBYFcHKzsfc90#provenance http://bio2rdf.org/drugbank_resource:DB00203_DB00872_nanopub.RAOp_x3rtCMBNgEaUesKgW3AqrTRwagCaBYFcHKzsfc90#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00203_DB00872_nanopub.RAOp_x3rtCMBNgEaUesKgW3AqrTRwagCaBYFcHKzsfc90#publicationInfo http://bio2rdf.org/drugbank_resource:DB00203_DB00872_nanopub.RAOp_x3rtCMBNgEaUesKgW3AqrTRwagCaBYFcHKzsfc90#signature.MCwCFC6rw6u-y1YV http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00203_DB00872_nanopub.RAOp_x3rtCMBNgEaUesKgW3AqrTRwagCaBYFcHKzsfc90#signature.MCwCFC6rw6u-y1YV http://purl.org/nanopub/x/hasSignature MCwCFC6rw6u+y1YV2P6BG0xAgjM2oz0sAhRmYadmGogk3RhBOO0J2o9RLQhu1w== http://bio2rdf.org/drugbank_resource:DB00203_DB00872_nanopub.RAOp_x3rtCMBNgEaUesKgW3AqrTRwagCaBYFcHKzsfc90#signature.MCwCFC6rw6u-y1YV http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00203_DB00872_nanopub.RAOp_x3rtCMBNgEaUesKgW3AqrTRwagCaBYFcHKzsfc90 http://purl.org/dc/terms/created 2018-03-30T11:12:26.800+02:00 http://bio2rdf.org/drugbank_resource:DB00203_DB00872_nanopub.RAOp_x3rtCMBNgEaUesKgW3AqrTRwagCaBYFcHKzsfc90 http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00203_DB00872_nanopub.RAOp_x3rtCMBNgEaUesKgW3AqrTRwagCaBYFcHKzsfc90 http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00203_DB00872_nanopub.RAOp_x3rtCMBNgEaUesKgW3AqrTRwagCaBYFcHKzsfc90#signature.MCwCFC6rw6u-y1YV http://bio2rdf.org/drugbank_resource:DB00203_DB00872_nanopub.RAOp_x3rtCMBNgEaUesKgW3AqrTRwagCaBYFcHKzsfc90 http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234